Title:Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer
VOLUME: 19 ISSUE: 3
Author(s):Marwa Elhossary, Nehah Hawash, Rehab Badawi, Mohamed Yousef, Sherief Abd-Elsalam*, Mohammed Elhendawy, Rania Wasfy, Sabry Abou-Saif, Amal ElBendary and Saber Ismail
Affiliation:Tropical Medicine Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta, Pathology Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta, Clinical Pathology Department, Tanta University, Tanta, Tropical Medicine Department, Tanta University, Tanta
Keywords:Colorectal cancer, dysplasia, polyps, screening, surveillance, chromocolonoscopy.
Abstract:
Background: Effective screening of colorectal cancer (CRC) in early stage
could reduce the advancement of CRC and therefore mortality. Effective screening is
based on either stool dependent tests or colon dependent examination.
Aims: The aim of the study was a comparative evaluation of chromocolonoscopy and Colon
Cancer-Specific Antigen-2 test for early detection of colorectal cancer in Egyptian patients.
Methods: This case control study was carried out on 55 patients classified into 3 groups:
Group I consisted of twenty patients with precancerous lesions detected by colonoscopy,
Group II consisted of twenty patients diagnosed with colorectal cancer and Group III consisted
of fifteen individuals (who underwent colonoscopy for other indications) as a control
group. All the subjects were subjected to measure occult blood in the stool, measurement
of Colon Cancer-Specific Antigen-2 level in serum and tissue and chromo colonoscopy using
Indigo Carmine stain.
Results: In group II, there was a statistically significant increase in CCSA2 in serum as
compared to the other 2 groups. Cutoff >11.3 CCSA2 in serum showed 65% sensitivity,
85% specificity, 81.2% PPV, 70.8% NPV and 70.3% accuracy in the differentiation of
group II with cancer colon from group I with premalignant colonic lesions. A cutoff > 9.1
CCSA2 in serum showed 95% sensitivity, 46.67% specificity, 70.4% PPV, 87.5% NPV
and 73.5% accuracy in differentiating group II with cancer colon from normal controls
(group III).
Conclusion: CCSA-2 level in serum was significantly higher in cancer colon. Chromoendoscopy
has a role in the detection of polyps, both neoplastic and non-neoplastic.
